Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 12:30 PM View:  | Robinson James A. Jr. PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 8,385 | -- | -- | (100%) 8.38K to 0 | |
| 31-Mar-21 12:30 PM View: | Kurstjens Sef Director | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 21,480 | -- | -- | (100%) 21.48K to 0 | |
| 31-Mar-21 12:30 PM View: | Legault Pierre Director | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 21,480 | -- | -- | (100%) 21.48K to 0 | |
| 31-Mar-21 12:30 PM View: | Potter Myrtle S Director | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 21,480 | -- | -- | (100%) 21.48K to 0 | |
| 31-Mar-21 12:30 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 124,447 | -- | -- | (100%) 124.45K to 0 | |
| 31-Mar-21 12:30 PM View: | Hindman James M. Director | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 9,000 | -- | -- | (100%) 9.0K to 0 | |
| 31-Mar-21 12:30 PM View: | Ocampo Christine PAO; CAO/Urovant Sciences,Inc. | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 78,781 | -- | -- | (100%) 78.78K to 0 | |
| 31-Mar-21 12:30 PM View: | Bansal Ajay See Remarks | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 140,098 | -- | -- | (100%) 140.1K to 0 | |
| 31-Mar-21 12:30 PM View: | Johnston Walt See Remarks | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 109,139 | -- | -- | (100%) 109.14K to 0 | |
| 31-Mar-21 12:30 PM View: | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 29-Mar-21 | Disposition | 141,348 | -- | -- | (100%) 141.35K to 0 | |
| 12-Jan-21 7:02 PM View: | Robinson James A. Jr. PEO; CEO/Urovant Sciences, Inc Director | Urovant Sciences Ltd. (UROV) | 10-Jan-21 | Payment of Exercise | 4,095 | $16.11 | $65,970.50 | (33%) 12.48K to 8.38K | (< 1%) |
| 08-Jan-21 6:29 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 07-Jan-21 | Payment of Exercise | 4,761 | $16.09 | $76,604.50 | (4%) 129.21K to 124.45K | (< 1%) |
| 08-Jan-21 6:30 PM View: | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 07-Jan-21 | Payment of Exercise | 5,810 | $16.09 | $93,482.90 | (4%) 147.16K to 141.35K | (< 1%) |
| 23-Jul-20 4:35 PM View: | Hindman James M. Director | Urovant Sciences Ltd. (UROV) | 21-Jul-20 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 23-Jul-20 4:28 PM View: | Kurstjens Sef Director | Urovant Sciences Ltd. (UROV) | 21-Jul-20 | Grant | 9,000 | -- | -- | 72% 12.48K to 21.48K | |
| 23-Jul-20 4:33 PM View: | Legault Pierre Director | Urovant Sciences Ltd. (UROV) | 21-Jul-20 | Grant | 9,000 | -- | -- | 72% 12.48K to 21.48K | |
| 23-Jul-20 4:31 PM View: | Potter Myrtle S Director | Urovant Sciences Ltd. (UROV) | 21-Jul-20 | Grant | 9,000 | -- | -- | 72% 12.48K to 21.48K | |
| 03-Jun-20 6:50 PM View: | Johnston Walt SVP, Commercial, USI | Urovant Sciences Ltd. (UROV) | 02-Jun-20 | Grant | 108,647 | -- | -- | 100% 0 to 108.65K | |
| 04-May-20 4:53 PM View: | Ocampo Christine PAO;CAO/Urovant Sciences, Inc | Urovant Sciences Ltd. (UROV) | 01-May-20 | Grant | 44,346 | -- | -- | 135% 32.83K to 77.18K | |
| 04-May-20 4:57 PM View: | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 01-May-20 | Grant | 83,149 | -- | -- | 134% 62.13K to 145.28K | |
| 04-May-20 4:51 PM View: | Bansal Ajay PFO;CFO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 01-May-20 | Grant | 63,659 | -- | -- | 85% 75.0K to 138.66K | |
| 04-May-20 4:55 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 01-May-20 | Grant | 77,606 | -- | -- | 155% 50.0K to 127.61K | |
| 21-Feb-20 6:42 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Disposition (other) | 75,212 | $13.08 | $983,773.00 | (27%) 274.89K to 199.68K | (24%) |
| 21-Feb-20 6:42 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Disposition (other) | 15,165 | $13.08 | $198,358.00 | (23%) 65.17K to 50.0K | (24%) |
| 21-Feb-20 6:42 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Payment of Exercise | 34,835 | $13.08 | $455,642.00 | (35%) 100.0K to 65.17K | (24%) |
| 21-Feb-20 6:42 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Option Exercise | 50,000 | $6.88 | $344,000.00 | 100% 50.0K to 100.0K | |
| 21-Feb-20 5:54 PM View: | Sumitomo Chemical Co., Ltd. | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Market Purchase | 103,250 | $13.08 | $1,350,510.00 | < 1% 22.86M to 22.96M | 24% |
| 21-Feb-20 6:42 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Payment of Exercise | 104,788 | $13.08 | $1,370,630.00 | (28%) 379.68K to 274.89K | (24%) |
| 21-Feb-20 6:42 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 19-Feb-20 | Option Exercise | 180,000 | $3.86 | $694,800.00 | 90% 199.68K to 379.68K | |
| 14-Jan-20 4:09 PM View: | Robinson James A. Jr. Director | Urovant Sciences Ltd. (UROV) | 10-Jan-20 | Grant | 12,480 | -- | -- | 100% 0 to 12.48K | |
| 14-Jan-20 4:04 PM View: | Kurstjens Sef Director | Urovant Sciences Ltd. (UROV) | 10-Jan-20 | Grant | 12,480 | -- | -- | 100% 0 to 12.48K | |
| 14-Jan-20 4:06 PM View: | Legault Pierre Director | Urovant Sciences Ltd. (UROV) | 10-Jan-20 | Grant | 12,480 | -- | -- | 100% 0 to 12.48K | |
| 14-Jan-20 4:07 PM View: | Potter Myrtle S Director | Urovant Sciences Ltd. (UROV) | 10-Jan-20 | Grant | 12,480 | -- | -- | 100% 0 to 12.48K | |
| 09-Jan-20 4:32 PM View: | Ocampo Christine PAO;CAO/Urovant Sciences, Inc | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 32,833 | -- | -- | 100% 0 to 32.83K | |
| 09-Jan-20 4:32 PM View: | Haag-Molkenteller Cornelia CMO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 62,128 | -- | -- | 100% 0 to 62.13K | |
| 09-Jan-20 4:33 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 199,680 | -- | -- | 100% 0 to 199.68K | |
| 09-Jan-20 4:30 PM View: | Smith Bryan E. GC/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 07-Jan-20 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 31-Dec-19 4:45 PM View: | Roivant Sciences Ltd. 10% Owner | Urovant Sciences Ltd. (UROV) | 27-Dec-19 | Sale | 22,860,000 | -- | -- | (100%) 22.86M to 0 | |
| 11-Dec-19 5:01 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 09-Dec-19 | Market Option Sale | 120,000 | $12.78 | $1,533,600.00 | (100%) 120.0K to 0 | (27%) |
| 11-Dec-19 5:01 PM View: | Katkin Keith PEO;CEO/Urovant Sciences, Inc. Director | Urovant Sciences Ltd. (UROV) | 09-Dec-19 | Option Exercise | 120,000 | $3.86 | $463,200.00 | 100% 0 to 120.0K | |
| 05-Nov-19 7:45 PM View: | Bansal Ajay PFO;CFO/Urovant Sciences, Inc. | Urovant Sciences Ltd. (UROV) | 05-Nov-19 | Grant | 75,000 | -- | -- | 100% 0 to 75.0K | |
| 19-Jun-19 6:30 PM View: | MacHado Clarence Patrick 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:24 PM View: | Dexxon Holdings Ltd. 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 45.7M to 45.71M | 99% |
| 19-Jun-19 6:28 PM View: | Viking Global Investors Lp 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:29 PM View: | Viking Global Performance LLC 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:20 PM View: | Lo Andrew 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:52 PM View: | Qvt Associates Gp LLC 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:00 PM View: | Roivant Sciences Ltd. 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:30 PM View: | Svf Investments (uk) Ltd 10% Owner | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:28 PM View: | Viking Global Investors Lp 10% Owner | Urovant Sciences Ltd. (UROV) | 18-Jun-19 | Market Purchase (Planned) Duplicate | 6,706 | $8.21 | $55,061.00 | < 1% 22.85M to 22.86M | 98% |
